Summary
The pharmacokinetics of single- and multiple-dose administration of tenoxicam 20 mg were evaluated in 8 healthy males. Maximum plasma concentration (Cmax) after the first dose was 2.76±0.48 μg/ml (mean±s.d.) and the time to reach Cmax (Tmax) was 5.0±3.0 h. The area under the plasma concentration-time curve (AUCo-∼) after a single administration of tenoxicam was 242.5±73.5 μg x h/ml. The elimination half-life (t 1/2 ) was 66.3±15.8 h and the plasma concentration at 24 hours after dosing (Cmin) was 1.84±0.33 μg/ml. Steady-state plasma concentrations of tenoxicam were virtually reached after 10 consecutive daily doses. At steady-state, Cmax averaged 13.63±3.33 μg/ml and Tmax remained 5.0±3.0 hours. AUC within a dosing interval at steady-state was 262.2±67.0 μg x h/ml, Cminss was 9.67±3.25 μg/ml, and t 1/2 averaged 74.2±13.3 h. The average fluctuation during multiple-dose administration was 26.8±8.0% and the accumulation ratio was 5.82±0.60. Steady-state pharmacokinetic parameters predicted from the first-dose data slightly underestimated observed values, but the results supported the assumption of linear pharmacokinetics during multiple-dose tenoxicam administration.
Similar content being viewed by others
References
Dell D., Joly R., Meister W., Arnold W., Partos C, Guldimann B. (1984): Determination of tenoxicam and the isolation, identification and determination of Ro 17–6661, its major metabolite, in human urine. J. Chromatogr., 317, 483–492.
Crevoisier C, Heizmann P. (1986): Pharmacokinetics of tenoxicam. In: Roxborough S.M. ed., Tenoxicam: Presentations to the EULAR Symposium. Basel, EULAR. Litera Rheumatologica, 5, 7–15.
Heintz R, Guentert T.W. (1986): Pharmacokinetic profile of tenoxicam. In: Fermer H., Stoiber W. eds, Tenoxicam, a New Nonsteroidal Anti-inflammatory Drug. Basel, EULAR. Litera Rheumatologica, 6, 23–34.
Heintz R.C., Guentert T.W., Enrico J.F., Dubach U.C., Brandt R, Jeunet F.S. (1984): Pharmacokinetics of tenoxicam in healthy human volunteers. Eur. J. Rheumatol. Inflamm., 7, 33–44.
Bird H A, Allen J.G, Dixon J.S., Wright V. (1985): A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid. Eur. J. Rheumatol. Inflamm., 8, 47–52.
Francis R.J., Dixon J.S., Lowe J.R., Harris P.A. (1985): The effects of food and of antacid on the single oral dose pharmacokinetics of tenoxicam. Eur. J. Drug Metab. Pharmacokinet., 10, 309–314.
Horber F.F., Guentert T.W., Weidekamm E., Heizmann P., Descoeudres C., Frey F.J. (1986): Pharmacokinetics of tenoxicam in patients with impaired renal function. Eur J. Clin. Pharmacol, 29, 697–701.
Bird H.A., Francis R.J., LeGallez P., Hill J., Dixon J.S., Allen J.G., Wright V. (1985): Single and multiple oral dose pharmacokinetics of tenoxicam in the elderly. Eur. J. Rheumatol. Inflamm., 8, 60–69.
Hamdy R.C., Mumane B., Perera N., Woocock K., Koch I.M. (1982): The pharmacokinetics of benoxaprofen in elderly subjects. Eur. J. Rheumatol. Inflamm., 5, 69–75.
Kamal A., Koch I.M. (1982): Pharmacokinetic studies of benoxaprofen in geriatric patients. Eur. J. Rheumatol. Inflamm., 5, 76–81.
Advenier C., Roux A., Gobert C., Massias P., Varoquaux O., Flouvat B. (1983): Pharmacokinetics of ketoprofen in the elderly. Br. J. Clin. Pharmacol., 16, 65–70.
Ritch A.E.S., Perera W.N.R., Jones C.J. (1982): Pharmacokinetics of azapropazone in the elderly. Br. J. Clin. Pharmacol., 14, 116–119.
Richardson C.I., Blocka K.L.N., Ross S.G., Verbeeck R.K. (1985): Effects of age and sex on piroxicam disposition. Clin. Pharmacol. Ther., 37, 13–18.
Heizmann P., Kömer J., Zinapold K. (1986): Determination of tenoxicam in human plasma by high-performance liquid chromatography. J. Chromatogr., 374, 95–102.
Metzler C.M., Elfring G.L., Even A.J. (1974): A package of computer programs for pharmacokinetic modelling. Biometrics, 30, 562–563.
Meystre A., Leishman B., Eckert M. (1982): NONLIN: A new version for simplified use in BASIC computer systems. Meth. Inf. Med., 21, 187–190.
Richardson C.J., Blocka K.L.N., Ross S.G., Verbeeck R.K. (1987): Piroxicam and 5′-hydroxypiroxicam kinetics following multiple dose administration of piroxicam. Eur. J. Clin. Pharmacol, 32, 89–91.
Colburn W.A. (1983): Estimating the accumulation of drugs. J. Pharm. Sci.,72, 833–834.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crevoisier, C., Heizmann, P., Forgo, I. et al. Plasma tenoxicam concentrations after single and multiple oral doses. Eur. J. Drug Metab. Pharmacokinet. 14, 23–27 (1989). https://doi.org/10.1007/BF03190838
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03190838